Alpha Cognition announces publication of patent application
The application relates to a proprietary manufacturing process for ZUNVEYL®.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
The application relates to a proprietary manufacturing process for ZUNVEYL®.
For best results when printing this announcement, please click on link below: Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL® Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition" or the "Company"), a biopharmaceutical company developing and c
Alpha Cognition said the USPTO published a U.S. patent application relating to its proprietary manufacturing process for ZUNVEYL.